Reading the Signs: Recognizing Early Congestion
Daniel R. Bensimhon, MD
Beyond the IV Pole: Introducing SC Furosemide
Craig J. Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Closing the Loop: Coordinated Remote Management
Stephanie Barnes DNP, AGPNP-C, CHFN
Fluid Forward: Reimagining Decongestion Beyond the Hospital Walls
Brian P. Rose, PA-C, MPH
The Unmet Need in ASCVD: Why Targets Are Still Not Enough
Erin Michos
Advancing Lipid Care: CETP Inhibition and Overcoming Inertia in Modern ASCVD Management
Christie Ballantyne, MD
Philip Scheltens, MD, PhD
What Comes Next: Building the Future Lipid Toolbox
Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
Ellie Kelepouris, MD, FACP, FAHA
Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
James Burton, DM, FRCP
Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
Nihar R. Desai, MD, MPH
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
Pauline A. Swift, PhD
Potassium Binders to Optimize GDMT Therapy in HFrEF
The Binder Selection Playbook: Matching the Right Strategy to the Right Patient
From Episode to Empowerment
Jennifer Carlquist, PA-C
Choosing the Right Therapy for Patients With PSVT
How to Build a Standardized Episode Algorithm
Sean Pokorney, MD, MBA